Recent Finacing
Recent Raise
Cydan is an orphan‑drug accelerator that sources assets from academia, government and industry, de‑risks preclinical candidates for rare monogenic diseases, and forms spinouts to advance clinical development and approval.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors